Ads
related to: verve
Search results
A Guide To The Risks Of Investing In Verve Therapeutics Inc
Knox Daily· 14 hours agoVerve Therapeutics Inc’s filing revealed that its insider Ashe Andrew D. acquired Company’s shares for reported $0.48 million on May 14 ’24. In the deal valued at $6.26 per ...
Verve Therapeutics appoints new Chief Scientific Officer By Investing.com
Investing.com· 3 days agoVerve Therapeutics, a biotechnology firm focused on gene editing treatments for cardiovascular...
Swiss National Bank Boosts Stock Position in Verve Therapeutics, Inc. (NASDAQ:VERV)
ETF DAILY NEWS· 7 days agoSwiss National Bank lifted its position in Verve Therapeutics, Inc. (NASDAQ:VERV – Free Report) by 13.9% in the fourth quarter, Holdings Channel.com reports. The firm owned ...
Michael Weatherly Signs With Verve (EXCLUSIVE)
Variety via Yahoo News· 4 days agoMichael Weatherly has signed with Verve for representation, Variety has learned exclusively. Weatherly continues to be repped by Anonymous Content and...
Sexyy Red Stakes Her Claim With Scintillating 2024 Roots Picnic Set
Billboard via Yahoo News· 1 day agoSexyy Red may not be the hip-hop of 30 years ago, but the verve she brought to this year’s Roots...
The Best Albums Of 2024 (So Far)
SPIN via AOL· 8 hours agoBut it’s only superficially a return to form, even if it does come after two albums that more-than-gently nudged her music in new directions. Play these...
Donald Trump Is a Convicted Felon. Democrats Must Shout It From the Rooftops.
The Nation· 6 hours agoBiden kept walking away, said nothing, then turned to face reporters with an enigmatic smile. Axios...
50 Box Office Bombs Totally Worth Watching
Lifehacker· 2 hours agoBritish impresario Malcolm McLaren’s headstone reads, “Better a spectacular failure, than a benign success.” What follows are 50 films that didn’t...
Sarah McLachlan Is Resurfacing
New York Times· 5 days agoSarah McLachlan was just 30 hours from beginning her first full-band tour in a decade, and she could not sing. “I’m so energized by music, now that I’m...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoVerve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today ...
